Showing posts with label Karolinska Institutet's Alzheimer's Disease Research Center. Show all posts
Showing posts with label Karolinska Institutet's Alzheimer's Disease Research Center. Show all posts

Monday, June 23, 2014

Alzheimer's Disease Research Center

Alzheimer's Disease Research Center
Alzheimer's disease is a condition that affects the nervous system of an individual, rendering the patient useless in terms of taking care of themselves or even remembering things. While the disease does not directly kill a person, it makes the patient susceptible to different ailments that may result in death. Alzheimer's disease starts with mild forgetfulness, which worsens till some mental faculties linked to intelligence and personality, are permanently destroyed.



While there are different treatments used to treat the Alzheimer's' disease, at the moment there is no permanent cure, but the Alzheimer's disease and research center is working closely with concerned authorities and experts in the health care field to ensure that a permanent cure is found. The treatment that is available at the moment is meant to delay the onset of the condition's symptoms, or help to counterbalance dementia and delusions that may occur in later stages of the disease.



Alzheimer's disease research center also propose that treatments for the disease are equally under study and investigation for possible efficacy. When the baby boomers get to the age at which they are susceptible to Alzheimer's, it becomes a very huge public concern; hence it is not something that the ADRC should wait to study. ADRC anticipates its occurrence and always endeavor to find ways of preventing it. If not, with the thousands and thousands of more people experiencing dementia and cognitive impairment, it can be quite a challenging and enormous health care concern. ADRC therefore studies the continuum of cognitive changes developing when people age, among other things.



Other functions of the Alzheimer's disease research center is to look for ways of predicting the occurrence of the disease, of course bettering the diagnostic techniques, pin-pointing high-risk individuals, and devising analytical tools that will aid in the pursuit for preventative treatments and the much awaited permanent cure. The US has over 30 Alzheimer's disease research centers, spread across the country and which are funded by the National Institute of Aging of the National Institutes of Health.



Note that the different research centers for AD have unique roles they play in fighting the disease, but they all work together when evaluating potential new medications and other treatments of the disease. The main goal of all ADRC's basic and clinical studies is to enhance patient care as well as function, and generally enhance the quality of life not only for the patient but also for the caregiver.